在缺血性中风患者中,CYP2C19基因型与临床表型和阿迪波金水平之间的关联:一项前性观察性研究
Jitender Gairolla1, Dheeraj Khurana2, Phulen Sarma3
1Microbiology, All India Institute of Medical Sciences, Rishikesh, IND.
CYP2C19的遗传变异与缺血性中风的发生和结果有关. 在中风患者中观察到较高的勒丁和较低的阿迪波涅丁水平,这表明它们在中风病原发生过程中的作用.
科学领域:
- 遗传学和分子生物学
- 心血管研究研究心血管研究
- 代谢综合征是代谢综合征的一种.
背景情况:
- 细胞染色体P450 (CYP450) 系统通过代谢药物和内源性化合物,参与血管疾病,包括中风.
- 阿迪波金类药物,如莱普丁 (促炎) 和阿迪波内克丁 (抗炎),与中风的发病有关.
- CYP2C19遗传变异影响各种物质的新陈代谢,可能影响中风风险和结果.
研究的目的:
- 调查CYP2C19遗传变异与缺血性中风的发生之间的联系.
- 评估CYP2C19多态性,阿迪波金水平 (莱普丁和阿迪波内克丁) 和中风结果之间的关系.
- 为了确定CYP2C19基因型是否影响中风复发,新的缺血性中风或死亡的复合结果.
主要方法:
- 预计招募204名缺血性中风患者和101名对照人群.
- 使用TaqMan测定和DNA测序,对CYP2C19单核酸多态 (SNPs) (*2, *17, *3, *4) 的基因定型.
- 通过酶相关免疫吸收试验 (ELISA) 测量血清勒丁和阿迪波涅丁水平.
- 统计分析比较中风患者与对照患者以及不同的CYP2C19代谢器表型 (IM/PM与EM/UM).
主要成果:
- SNP2与中风发生有显著的积极关联.
- 单元型AC和GT (SNP1/SNP2) 与缺血性中风发生有很强的关联,即使对年龄和性别进行了调整.
- 该AC单元型与复合结果 (中风复发,新的缺血性中风或死亡) 和死亡显著相关.
- 与对照组相比,中风患者表现出明显更高的勒素和较低的阿迪波内克丁水平.
- 中级/低代谢 (IM/PM) CYP2C19表型中丁水平较高,他们也显示出更高复合结果发病率的趋势.
结论:
- CYP2C19多态可能在缺血性中风的发病过程中发挥重要作用.
- 素可能是动脉样硬化和早期中风后炎症的潜在生物标志物.
- 需要对更大的样本进行进一步的研究,以证实这些发现并阐明相关机制.
更多相关视频
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
06:04Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
相关概念视频
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Hypertension III: Clinical Manifestations and Diagnostic Studies
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
